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1
1.1

INTRODUCTION

Transcription Factors
Transcription factors are a diverse family of proteins that bind to the promoter region, a

specific DNA section upstream of a gene, in order to regulate its expression. Transcription
factors can also bind to multi-subunit protein complexes to manipulate transcription either
negatively or positively [2-7], and they determine how cells function by determining the time
and place of their gene expression.
Transcription factors that control homeotic genes (i.e. genes that control the pattern of
body formation) usually are vital for the normal development of the organism. In Drosophila,
the transcription factor Bicoid, for instance, is necessary for the embryonic development of the
anterior half of the embryo. Embryos with a mutation in Bicoid grow into larva with posterior
structures at both ends and with two spiracles, instead of one, at the posterior end [8, 9]. Another
function of transcription factors is to determine whether a gene functions or not at a given time.
For example, HES mutations in the developing mouse embryo cause neural progenitor cells to
prematurely differentiate causing neural defects [10] and sometimes small and deformed brain
structures [11].
Transcription factors are often grouped into families based on their sequence
similarity and their structure. Examples of different transcription factor families include winged
helix, zinc fingers, homeodomain proteins, zinc-finger proteins, and basic helix loop helix
proteins. These different families also typically have characteristic functions. For instance, in
humans, the transcription factor T18 is part of the zinc-finger family. T18 acts as a breast cancer
tumor suppressor [12]. In plants, many transcription factors from the family of basic
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region/leucine zipper motif (bZIP) proteins, like the bZIP protein lotus, regulate processes
including photomorphogenesis, leaf and seed development [13, 14].

1.2

The Basic Helix Loop Helix (bHLH) superfamily
Members of the basic helix-loop-helix (bHLH) transcription factor family have two

highly conserved domains, the basic domain and the helix-loop-helix domain. The basic domain
is located at the N-terminus; this domain binds to specific sequences of DNA upstream of the
promoter region [15]. The second domain contains an HLH domain located at the C-terminus
formed by two amphipathic helices connected by a loop region consisting of amino acids [16].
The HLH domain interacts with other proteins. These domains are approximately 60 amino
acids long [15]. The HLH domain binds to other proteins to form homodimeric and
heterodimeric complexes [17]. For example, bHLH proteins LYL1 form a heterodimeric
complex with TCF3 in hematolymphoid cells to regulate blood vessel maturation and
hematopoiesis [18]. bHLH transcription factors also have the ability to differentially regulate
transcription based dimerization. For instance, in the fungal plant Fusarium oxysporum, the
bHLH protein FoSTUA differentially regulates the development of two kinds of asexual pores,
macroconidia and microconidia. FoStuA acts as a positive regulator for macroconidia and as a
negative regulator for chlamydospores during development [19].
Different attempts have been made to subcategorize bHLH proteins. Atchley and Fitch
[20], subdivided the bHLH proteins into four groups based on their binding to DNA at the
hexanucleotide E-box, the amino acid patterns in other components of the motif, and the
presence/absence of a leucine zipper. Group A proteins bind to the E-box (CAGCTG) usually to
activate transcription. They have a distinctive pattern of amino acids at sites 5, 8, and 13. This
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group has only small aliphatic residues. An example of a group A protein in mammals is the
MyoD protein family. Group B proteins bind to the G-box (CACGTG). This group has
arginine at site 13, a basic amino acid at site 5, and an E-box configuration at sites 5–8-13.
Protein families with a LZ motif are included in group B. Sequences with an LZ have a very high
frequency of N residues (93%). An example of a group B protein in Drosophila is the Hairy and
Enhancer of split bHLH. Group C has the PAS domain, which is a protein-protein interaction
region. Proteins with a PAS domain usually function as signal sensors [21]. For instance, human
PAS proteins include hypoxia-inducible factors and voltage-sensitive ion channel proteins [22].
Group D proteins lack the DNA binding basic region, and thus, are unable to bind DNA, but they
can form heterodimers with other bHLH proteins usually as negative regulators. An example of
group D in mammals is the ID protein family [23, 24].
The superfamily bHLH is found in many organisms including yeast, mice, worms, and
humans. bHLH transcription factors are involved in the regulation of many developmental
processes including, cardiovascular development [25], mouse brain development [26, 27] ,
neurogenesis [28], cell cycle regulation, and embryogenesis [10, 29]. They typically act in
cascades, one after the other, to cause increasing degrees of specialization. For example, the
regulation of the cell elongation (i.e. cell specialization) in Arabidopsis depends on a chain of
antagonistic switches comprised of transcription factors, PREs, IBH1, and HBI1 [30].
Transcriptional regulators are required for the development of differentiated neurons.
Many proteins are involved in neuron differentiation and HLH proteins regulate parts of this
process. In mammals, different bHLH proteins work in a cascade to control different steps
behind neurogenesis. In mice, two bHLH transcription factors, Ascl1 and Hand2, are necessary
at every step of the cascade for proper parasympathetic and sympathetic neuron development,
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respectively [31]. Ascl1 has also been implicated in the differentiation of the P19 EC cells into
neuronal cells, and reduction of Ascl1 causes delayed neurogenesis of the P19 EC cells [32].
Hand 2 impacts development of the enteric nervous system (ENS). Mutations in Hand2 affect
both neural precursor and neuron numbers, such as complete loss of neuronal nitric oxide
synthase (NOS) and vasoactive intestinal peptide (VIP) neurons [33].

1.3

Hairy/Enhancer of Split (HES)
The Hairy/Enhancer of Split (HES) proteins form a sub-family within the bHLH

superfamily. The founding members of the HES family were first described in Drosophila
where it was demonstrated that HES proteins are direct targets of Notch signaling [34-36]. Notch
signaling is a conserved cell to cell communication necessary for proper development in many
organisms. Notch signaling has been implicated in the development of embryogenesis, the
nervous system, the cardiovascular system, and the endocrine system [11, 34, 37, 38]. In
humans, for instance, a mutation in NOTCH1 causes T-cell acute lymphoblastic leukemia [39].
Proteins of the HES family have three structural domains: bHLH, Orange, and WRPW.
The bHLH domain contains a highly conserved proline residue that is typically absent in other
members of the bHLH family. The Orange domain consists of two amphipathic helices and
regulates the selection of bHLH heterodimer partners [11, 35]. For example, the Orange domain
in Xenopus is required for heterodimerization of XHRT1 with Xhairy2b [40]. The WRPW
domain is found at the C-terminal end of the protein and is required for repression of
transcription. This domain consists of four amino acids Trp-Arg-Pro-Trp that mediates
degradation of its own protein. For instance, WRPW recruits Groucho to actively repress
transcription [41, 42].
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Even though HES proteins are critical for normal function and play central roles in
embryogenesis by maintaining progenitor cells in an undifferentiated state [11], little is known
about how they work. HES mutations have been associated with lung and breast cancer in
mammals [43, 44] and oocyte death [29].
1.4

REF-1 family proteins
The members of the REF-1 family in C. elegans, like the HES family, are also a direct

target of the Notch signaling [45] , but they also act in Notch-independent functions [46]. Both
families share a sequence similarity at the bHLH domain[2], and they regulate a variety of target
genes that influence embryo development. Therefore, the REF-1 family members are considered
functional homologs of the HES family.
Unlike other bHLH members, the REF-1 family proteins are distinguished by the
presence of two basic helix-loop helix domains instead of one [2], and unlike the HES proteins,
REF-1 proteins do not have a conserved Orange domain [47]. The six members of the REF-1
family are REF-1(HLH-24), HLH-25, HLH-26, HLH-27, HLH-28 and HLH-29. The REF-1
family also lacks the WRPW domain, but at the C-terminal of each member has a slightly
different pentapeptide repeat sequence: REF-1 has FRPWE; HLH-25 has LDIIN; HLH-26 has
IDIVG; HLH-27 has VDISN; and HLH-28 and HLH-29 have IDIIG (Figure 1). These
pentapeptide repeat sequences have similar net charges to those of the WRPW sequences, and
the sequences in REF-1 has been shown to interact with the C. elegans Groucho homolog [45].
Alignment of bHLH domains from Drosophila HES-6, the C. elegans REF-1 family and
the C. briggsae showed that the first bHLH domain in the REF-1 family proteins is more closely
related to each other than to the second bHLH domain, and the first bHLH domain is also
significantly more similarto the bHLH domain in the Hairy/E(spl)/LIN-22 [2]. Therefore, we
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postulated that the second bHLH domain in the REF-1 family could functionally replace the
Orange domain and may act to provide stability during protein-protein interactions.

Figure 1 Domain Organization of HES and REF-1 family members.
This figure was adapted from Dawson at el.1995 and Neves et al. 2005. Unlike HES, the REF-1 family
lacks the Orange domain present in HES. It is postulated that the second basic helix-loop-helix domain
can functionally substitute for the orange domain.

REF-1 was the first member to be studied. It has been shown that REF-1 regulates HOX
genes, genes that control the body plan of the embryo; thus making it an important transcription
factors needed for development during embryogenesis [48]. Mutations to ref-1 affect cell fate
decisions in different body regions along the C. elegans AP body axis, giving rise to aberrant
physical phenotypes such as irregular head shapes and multivulva [48]. REF-1 also affects the V
ray lineage in C. elegans males resulting in a partial transformation of the ray identity from V6 to
V5 [48, 49].
The hlh-28 gene is nearly identical to hlh-29 and their gene products are identical [50].
Therefore they are usually studied together. They are expressed in all cells of the early MS and
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E lineages. Both of these members are also involved in embryonic development and
reproduction. RNAi against hlh-29/hlh-28 affects the embryonic viability, adult egg-laying and
organismal homeostasis [51]. Also, HLH-29 regulates the ability of oocytes to enter and exit the
spermatheca, within the IP3 signaling pathway [52]
Even though HLH-26 and HLH-27 are known to activate in response to Notch signaling
during embryogenesis [2], they have not yet been studied extensively. However, hlh-27 and hlh25 are almost identical and may work redundantly in the mesoderm and endoderm networks
in C. elegans [46, 53].
HLH-25 is expressed during embryonic development in response to Notch signaling [45],
in Abp granddaughters (beginning after eight-cell stage) and in four of the EMS granddaughters
(MSaa, MSap, MSpa,Mspp) [45]. HLH-27 is also expressed in the early MS lineage [46, 53].
hlh-25 is one of the MED-1 target genes which participates in specifying the mesendoderm [54].
It has been shown that overexpression of hlh-25 restores muscle differentiation in development
in a small proportion of embryos with skn-1 and pal-1 mutations [46, 53]. Since the cascade
controlling muscle development incudes members of the bHLH family, MyoD, myogenin, Myf5,
and MRF4, it is believed that HLH-25 may be involved in muscle development [46, 53].
Using enriched GO annotations, previous studies have shown that HLH-25 DNA binding
specificities are associated with candidate target genes required for cytoskeleton, reproduction,
cuticle/molting, secretion, cell division, locomotion, signaling, development, and metabolism
[55]. In preliminary studies from our laboratory, genes identified by gene expression microarray
analysis of hlh-25 mutants were grouped under regulation of growth, embryonic development
ending in birth or egg hatching, nematode larval development, positive regulation of growth,
post-embryonic development, and body morphogenesis.
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Grove et al [56] also used protein binding microarray (PBMs) assays to identify the DNA
binding sequence preferences of the bHLH dimers. They found that HLH-25 and the other REF1 family proteins can bind to DNA as homodimers, and that HLH-25 recognizes five different
consensus sequences. Interestingly, the REF-1 family member HLH-29 shared two of the five
HLH-25 recognition sequences (table 1) [55].

Table 1 DNA Consensus Sequences
Protein

CACGCG

CATGCG

CATACG

CACACG

CACGCT

HLH-25

X

X

X

X

X

HLH-27

X

X

X

HLH-29

X

X

We compared the target genes identified by the gene expression microarray studies from
our lab with those identified by PBM. A number of targets were on both lists. One target gene
found on both lists was daf-18, the C. elegans ortholog of PTEN. In humans, PTEN is a tumor
suppressor in human cancers [26]. Mutations to PTEN have resulted in the development of
glioblastoma, colon cancer, breast cancer, and prostate cancer [57-60]. PTEN is a phosphatase
protein involved in the regulation of the cell cycle and prevents cells from growing too rapidly
by preventing phosphorylation of the Akt/PKB signaling pathway which is responsible for cell
growth regulation [61-63]. In C. elegans, DAF-18, like PTEN, is a phosphatase protein involved
in cell regulation. DAF-18 also prevents phosphorylation of the AKT-1/AKT-2 complex in the
insulin pathway [64] which plays a role in, development, metabolism, and longevity [65-68].
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1.5

Caenorhabditis elegans
Caenorhabditis elegans (C. elegans) are transparent free-living, non-parasitic

microscopic nematodes measuring about 1 mm in length as adults. These round worms live in
soil environments and feed on bacteria [69-72]. In
laboratories, C. elegans grow in Petri-dish plates and
feed on E. coli. There are two sexes, a self-fertilizing
hermaphrodite and male. C. elegans have a short life
span of roughly one month.
The C. elegans life cycle is divided into the
following stages: embryos, four larvae stages: L1, L2,
L3, L4, and adults (Figure 2). When these animals
encounter a hostile environment such as high

Figure 2 C. elegans Life Cycle at 25°C.
<http://avery.rutgers.edu/WSSP/StudentS
cholars/project/introduction/worms.html>

temperatures, little or no food, or crowdedness, they
can go to an alternate stage called the dauer stage. During the dauer stage, C. elegans do not age,
eat or reproduce and their locomotion is reduced. Surprisingly, worms that encounter this stage
can live up to four months, four times longer than non-dauer animals. Morphologically they are
long, thin, and covered in a thick cuticle. When dauer-stage animals find a suitable environment
they resume their normal life cycle and molt directly to an L4 within a few hours [73].
C. elegans hermaphrodites have a “U” shape gonad. The gonad consists of two ovaries,
oviducts, spermatheca, and one uterus. There is a distal end (DTC) of the germline on each side
of the gonad where the somatic cells are situated (Figure 3). As these cells move through the
gonad they go through a series of phases. Once they reach the loop (bend of the gonad) they are
surrounded by plasma membrane in preparation for compartmentalization to form oocytes. Once
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fertilized, the oocytes undergo meiosis and are pushed to in the uterus, and the eggs are laid after
approximately thirty divisions. The fertilized
egg forms an eggshell that protects it from the
external environment [69, 72]. If plenty of
food is present, hermaphrodites who run out
of sperms may lay an average of 31
unfertilized eggs per worm [74].

Figure 3 C. elegans Hermaphrodites

1.6

Objective
Since previous studies suggest that HLH-25 may be critical for embryonic and larval

development, my objective is to further characterize HLH-25 and to precisely define its role
during embryonic and larval development. In order to achieve this objective, the following aims
were developed: to determine the temporal and spatial expression profile of HLH-25, to identify
phenotypes of hlh-25 mutants, to define the hlh-25 transcriptional network, and to determine if
HLH-25 is required for embryonic cell division. The key challenge in this genetic research is to
understand how the HLH-25 transcription factor affects the performances of its target genes by
examining phenotypes caused by hlh-25 mutations.
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2

2.1

EXPERIMENTAL METHODS

Nematodes Strains and Maintenance
The wild-type strain used in this work was Bristol N2. VC1220 [hlh-25 (ok1710) II.] and

RB712 (daf-18(ok480) IV.), was received from the Caenorhabditis Genetics Center (CGC). The
daf-18 transgenic reporter strain used was FS84 (daf-2(e1370) ; daf-18(mg198); fsEx84(daf-18
promoter::daf-18 cDNA::unc-54 3’UTR 20ng/ul + daf-18 promoter::GFP::unc-54 3’UTR
20ng/ul (in pPD95.75) + pRF4 100ng/ul) kindly provided by Dr. Florence Solari from Claude
Bernard University Lyon from the European Molecular Biology Laboratory. IC748, quIS18
[daf-18 genomic(+)] was provided by Dr. Ian D. Chin-Sang from Queen’s University, Kingston,
ON Canada. GR1673 (akt-2::GFP; pRF4 (rol-6)) was provided by Dr. Gary Ruvkun from
Harvard Medical School.
The hlh-25 transgenic reporter strain used was CMJ3001 (Phlh-25::GFP(A); pRF4 (rol6). Other strains used were CMJ4001 (daf-18 promoter::daf-18 cDNA::unc-54 3’UTR 20ng/ul
+ daf-18 promoter::GFP::unc-54 3’UTR 20ng/ul (in pPD95.75) + pRF4 100ng/ul; hlh-25
(ok1710) II.),hlh-25(VC1220); CMJ4004 (Phlh-25::GFP); Pmyo-2::mCherry::unc-54utr), and
CMJ4003(α-tubulin::GFP; hlh-25 (ok1710) II.)
Animals were maintained on nematode growth medium (NGM) with OP50 as a food
source, previously described [75]. For synchronization, embryos were collected by treatment
with sodium hypochlorite, as previously described, [76, 77], with the following exceptions.
Only 500µL of 5M KOH and 1mL of household bleach were added and the worms were shaken
vigorously for no more than six minutes.
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2.2

Constructs and Transgenic Lines
To generate Phlh-25::GFP, 1570 bp upstream of the first ATG of hlh-25 in the coding

sequence was amplified by PCR (see appendix A for primers) using Phusion® High-Fidelity PCR
Master Mix. For the HLH-25 target genes daf-18, vha-1, akt-2, pqn-95, ima-1, imp-2, ntl-4,
thoc-2, and ran-1, 2,000 bp upstream of the first ATG in the coding sequence was amplified
using Phusion® High-Fidelity PCR Master Mix. All PCR was done using the DNA Engine
Dyand Peltier Thermal Cycler and the products purified using the Qiagen QIAquick PCR
Purification Kit. The transgenes were cloned using standard techniques (Figure 4) [78, 79].

Figure 4 Transcription Reporter
Schematic image of a transgenic DNA construct were the (GFP) gene is under the control
of the selected genes promoter producing a green fluorescent protein when translated into
the region were the gene is expressed. Plasmid 1490: pPD95.67 (Fire Vector)
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2.3

Nematode Transformation
Microinjection has been previously described [80, 81] . The Phlh-25::GFP DNA

construct was microinjected as a“simple” array and was co-injected with rol-6(su1006) as a
marker which induces a dominant "roller" phenotype [82] in a 1:1 ratio. The HLH-25 target in a
DNA constructs were microinjected directly into the syncytial gonad as “complex” arrays in low
copy number to prevent transgene silencing [81, 83]. The DNA solution consisted of the
following components: 100 ng/µL of genomic DNA cut with PvuII, 1ng/µL of linearized
construct, and 1ng/µL of marker rol-6(su1006). A PCR product of genomic DNA from 1541bp
upstream to 770 bp downstream of the hlh-25 coding sequence was co-injected with Pmyo2::mCherry.

Figure 5 Microinjection.
A) Site for microinjection of the DNA in the cytoplasm of the syncytial gonad. B)
Sample needle used for microinjection.
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2.4

Microscopy
The transgenic worms were exposed to ultra-violet (UV) to analyze their expression and

position by comparing GFP (green fluorescent protein) and DIC (differential interference
contrast) images. Animals were anesthetized with 0.2% levamisole [84], mounted on 2.0%
agarose pads and imaged using a Nikon Eclipse 90i microscope equipped with a Nikon Coolsnap
CCD camera.
2.5

Embryonic Lethality and Unfertilized Oocytes Assay
Twenty virgin L4 stage animals of each strain were singled out and placed on fresh plates

every 24 hours. Embryonic lethality was determined by counting the number of non-hatched
embryos divided by the total progeny (non-hatched and hatched) and subtracting the number
from 100% to obtain the lethality percentage. Embryos that did not hatch after 24 hours were
scored as dead. The p-value of lethality was calculated using two-way ANOVA. The
unfertilized oocytes average was determined by moving another twenty L4 to a new plate daily
and counting the unfertilized eggs until death or nineteen days after egg lying was reached,
whichever ocurred first. The percentage and p-value was calculated using the Graphpad
Software Package.

2.6

Life Span Assay
Assays were conducted at 20°C. During the egg laying period, these worms were

transferred every two days to a new fresh NGM plates. The numbers of surviving, dead and
missing worms were counted each day. Animals were scored as dead when they no longer
responded to the touch of the platinum wire or were censored if missing [85, 86]. The Graphpad
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Software Package was used for statistical analysis and to calculate p-value, means and
percentiles.

2.7

Dauer Recovery Assay
In order to promote dauer formation more than 200 embryos were placed on each plate

containing very little food (10µL OP50) at 27° C for a minimum of 96 hours. Three day old
dauers were singled out to a plate with plenty of food (OP50, 75 uL) and moved to 20° C. Dauer
recovery was examined by monitoring five characteristics: fat accumulation, pharyngeal
pumping, visibility of crescent in vulvae, visibility of embryos, and visibility of eggs laid (Figure
26) [70, 87].

2.8

Mobility Assays

2.8.1 Locomotion and Thrashing Assay
Dauer and L4s were used to examine movement. The locomotion rate on solid media was
quantitated by counting body bends for one minute in a plate with no food [88]. The thrashing
rate was obtained by counting each lateral movement made by the worms when swimming in M9
buffer over a period of one minute [89].

2.9

Total RNA Isolation
Embryos, L4, and dauer animals were frozen at −80°C for a minimum of twenty- four

hours. Each pellet was resuspended in 100 µL of freshly made lysis buffer containing 0.5%
SDS, 5% 2-mercaptoethanol, 10 mM EDTA, 10 mM TrisHCl (pH 7.5), and 10 µL of Proteinase

16

K [(Thermo E0Ø491) (19.2mg/mL)]. The samples were incubated at 55°C shaking at 900 rpm
for 1 hour. RNA was extracted using a Quiagen RNeasy Plus Kit and with following the
protocol from the RNeasy Microhandbook for animal tissue.

2.10 RTqPCR
cDNA was synthesized using the high capacity cDNA Reverse Transcription Kit
(Applied Biosciences catalog #43674966), and following the instructions from the manufacturer.
cDNA synthesis reactions were performed in 20 µL reaction volumes containing 0.5 µg of total
RNA. Reverse transcriptase PCR assays were performed with Taqman Gene Expression Assays
(Applied Biosystems) for detection of amplicon, specific for each target gene, using relative
quantitation against the endogenous control gene pmp-3 [90]. For primer sequences see
appendix B.

2.11 Strain Crossing
Fifty hlh-25 young adult hermaphrodites were heat shocked at 35° C for 3 hours and
singled out in plates to screen for males [91]. Transgenic strains akt-2::GFP, daf-18::GFP, and
α-tubuline were crossed with hlh-25 animals. Each plate contained six males and one adult
hermaphrodite. To select progeny with the transgene and homozygous deletion of hlh-25, PCR
was used to amplify the hlh-25 gene using internal primers: Left 5’
ACCAAACCGGAGTTCTCAAA 3’; Right 5’ AGAATGGGACATCCCACAAA 3’. Deletion
was confirmed by agarose gel electrophoresis. The internal wild-type amplicon is 2,113 bp and
the deletion size is 1,550 bp.
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2.12 Live Embryo Imaging
Gravid adult worms were placed in a drop of M9
buffer over a glass slide. An incision was made with a
scalpel (or razor blade) at the vulva to release the eggs,
(Figure 6). Vaseline® Petroleum Jelly was applied on the
edges of a cover slip that was then placed over the glass
slide containing the embryos to lock moisture in. Less than

Figure 6 Release of embryos

ten eggs were placed per slide to prevent hypoxia. A time-lapse recording of epifluorescence
pictures at time intervals of three minutes was taken to track the first divisions of the embryo
with 40X or 60X objective [92].
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3

3.1

RESULTS

Temporal and Spatial expression profile of HLH-25
Even though it was previously shown that HLH-25 is expressed in response to Notch

signaling during embryogenesis, its full expression profile was unknown. As a first step to
understanding HLH-25 and to determine the full expression of hlh-25 in live animals, we
generated a transcriptional reporter. This reporter consisted of the gene encoding the green
fluorescent protein (GFP) under the control of the hlh-25 promoter. Using DIC imaging and
epifluorescent microscopy, I observed the transcriptional reporter expression in embryos, larvae,
including dauer larvae, and adult animals. According to our microarray analysis, HLH-25
regulates many important genes needed for development. Thus, I expected to observe expression
not only in embryos, but also in the larvae stages.

3.1.1

HLH-25 is expressed in embryos

I examined eggs in utero, immediately after fertilization, or after manual extraction from
adult hermaphrodites. I first detected expression of Phlh-25::GFP after the ten-cell stage (Figure
7). This result is consistent with previous reported expression after the first embryonic Notch
signaling event in C. elegans [45]. As the cells continued to divide mitotically, the expression
expanded to all cells on the outer surface of the embryo. During normal gastrulation, which
initiates at the 26-cell stage, wild-type animals progress from the bean stage to the tadpole stage,
and precursor cells of the gut, germline, pharynx and body wall muscles and mesoderm migrate
from the outer surface towards the interior of the embryo through the entry zone. I found that
hlh-25 expression correlated with migrating cells. Expression of Phlh-25::GFP during the bean
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stage was located only on the outer surface of the embryo (figure 7 -8 ); however, during the
comma stage the expression expanded. When the embryos reached the tadpole stage, I observed
expression in the entry zone along the ventral side, in part of the anterior where the future buccal
opening, or mouth, will form, and in the posterior region of the animal, where the future tail will
form. Interestingly, I detected no embryonic expression immediately prior to hatching, a result
which suggests that hlh-25 is actively silenced at some stage during embryogenesis.

3.1.2

HLH-25 is expressed in larval stages and in adults

After hatching, if food is available, C. elegans go through four larval stages before
reaching adulthood. During the first larval stage, L1, somatic gonad precursors start dividing.
At the end of L1 stage, five of the eight types of motor neurons are made, one of which is the
ventral nerve cord (VNC). The second larval stage is L2. During this stage, the somatic gonad
precursors continue dividing and give rise to the distal tip cells that are required for gonad
elongation. At the third larval stage, L3, the arms of the somatic gonad elongate, the
spermathecae are formed, and sperm production begins. In the fourth and final larval stage, L4,
sperm production stops and meiosis in the germline begins. Animals enter adulthood after
exiting the L4 stage. During adulthood, the reproductive system is complete; oocytes are made
and reproduction commences. I examined synchronized cultures of C. elegans hermaphrodites
through all of the larval stages, and in adults, to characterize hlh-25 expression. I did not detect
expression from the Phlh-25::GFP reporter in L1 stage animals. However, during the L2, L3,
and L4 stages, I observed expression in unidentified head and tail neurons, and in head and bodywall muscles (figure 9). I also detected expression in the midbody mechanosensory PDE
neuron. In adults, I continued to detect expression in the head and tail neurons, but not in the
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head or body-wall muscles (figure 10). I also detected weak expression in the ventral nerve cord
of some adults.

3.1.3

HLH-25 is expressed in the dauer stage

The dauer stage is an alternative stage that promotes survival when C. elegans encounter
a hostile environment. During this stage, animals grow a thicker cuticle that seals the buccal
cavity, slows metabolism and inhibits reproduction. To complete the expression profile of HLH25, I also examined Phlh-25::GFP expression during the dauer stage. I detected strong Phlh25::GFP expression in the head neurons and VNC of every dauer animal, and occasionally, in
the synaptic branches between VNC and the dorsal nerve cord (Figure 11-12). Because the
transgene expression was mosaic and highly variable, I was unable to identify which cell bodies
of the VNC were expressing the reporter.

3.2

Phenotypes of hlh-25 animals
To further characterize HLH-25, I sought to identify phenotypes of hlh-25 animals.

Because hlh-25 is expressed in embryos, neurons and muscles, I believe these results are
indicative of a possible role for HLH-25 in directing embryogenesis and body movement. Thus, I
examined C. elegans embryonic lethality, quantity of eggs laid, and movement.

3.2.1 HLH-25 affects embryogenesis
Embryos take approximately ten hours to develop following fertilization, going through a
series of division and folding before hatching. hlh-25 is expressed in the embryos in response to
Notch signaling, and expression continues throughout embryogenesis but ceases just before
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hatching. As a measure of the requirement for HLH-25 during embryogenesis, I examined
embryonic viability in mutant and wild-type animals.
Homozygous deletion of hlh-25 gave rise to embryonic lethality. I observed 54%
lethality in hlh-25 mutant embryos versus 14% embryo lethality in wild types embryos (Figure
13a), representing a 3.79 fold increase (P-value = 6.32E-14). These results correlate with a
previous genome-wide RNAi study which showed a 40% embryonic lethality for animals
subjected to hlh-25 RNAi. Deletion of hlh-25 also resulted in a reduced quantity of eggs laid.
hlh-25 animals laid a total average of 208 eggs, while wild-type animals laid an average of 249
(P-value = 0.0565) (Figure 13b).

3.2.2 hlh-25 animals have an increased unfertilized egg laying behavior
Wild-type C. elegans hermaphrodites produce approximately 300 sperm between L3 and
L4 stages. As the animals progress through L4, they cease sperm production and switch to
producing oocytes at late L4/early adulthood. As adults, fertilization is initiated when mature
oocytes are fertilized by sperm that reside in the spermatheca. Normally at 20°C, the onset of
fertilization and egg production begins at approximately 65 hours after hatching (~ 3days) and
continues until approximately 128 hours after hatching (~5.5 days) [93, 94]. Since oocyte
production is not the limiting factor, wild-type hermaphrodites that run out of sperm lay some
unfertilized oocytes, usually at day six. If plenty of food is present hermaphrodites may lay an
average of 31 unfertilized eggs per worm.
I found that hlh-25 animals lay more unfertilized oocytes than wild-type animals, and that
the production of unfertilized oocytes extended much further than in wild-type animals. As
shown in figure 14, both wild-type and hlh-25 animals begin to lay unfertilized oocytes as early
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as the second day of egg laying; however, hlh-25 animals lay significantly more unfertilized
oocytes each day. hlh-25 animals laid an average of 133unfertilized oocytes from egg laying
day 2 (4 days after hatching) to egg laying day 13 (15 days after hatching), while wild-type
animals laid an average of 27 unfertilized oocytes and stopped laying unfertilized eggs
completely by egg laying day 8 (10 days after hatching).

3.2.3 hlh-25 animals have a slower movement rate
Because the HLH-25 expression pattern is seen in both neurons and in muscles, and
because a number of the genes predicted to be HLH-25 targets are associated with GO term
locomotion, I hypothesized that that HLH-25 could be required for normal body movement.
hlh-25 animals have a normal sinusoidal movement, and their forward and reversal
movement on solid media appears normal [95]. Although I did not assay reversal frequency,
hlh-25 animals appear to have the same backing up phenotype as wild-type animals. Therefore, I
used two different assays to detect more subtle movement defects in hlh-25 animals at dauer and
L4 stages: locomotion on solid media and thrashing in M9 solution. In the locomotion assay, I
counted the number of body bends per minute, and in the thrashing assay, I counted each lateral
movement over a period of one minute. The results for both assays were generally the same: hlh25 animals moved slower than wild type animals at both developmental stages. Specifically, the
hlh-25 L4 stage and dauer stage animals moved with an average of 28 and 21 fewer body bendsper-minute than wild-type animals, respectively. Likewise, hlh-25 animals thrashed with an
average of 23 and 31 fewer bends per minute than wild-type animals at the L4 stage and the
dauer stage, respectively (Figure 15-16).
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3.2.4 HLH-25 affects organization and formation of the germline
The hermaphroditic reproductive system consists of two, U-shaped gonad arms
connected to a uterus and one spermatheca on each side (figure 3). In wild type animals, oocyte
production starts in the distal tip of the gonad arm and continues throughout the syncytial
section, where the multinucleated mass of cytoplasm has not separated into individual cells. In
the syncytial section, the germline nuclei go through mitosis and meiosis while being surrounded
by the cytoplasmic membrane. Oocytes start to compartmentalize when they reach the loop of
the gonad, and achieve full compartmentalization as they move closer to the spermatheca. In
wild type animals, fully cellularized (i.e. separated into distinct cells) oocytes have the
appearance of squared compartments with a narrow gap.
A number of the HLH-25 target genes are known to affect either mitotic or meiotic cell
division, including ran-1, mex-5, mex-6, and pos-1. Often animals with mutations in these genes
show germline abnormalities that include abnormally shaped or endomitotic oocytes.

I

examined the gonad arms of young adult hermaphrodites and found that in approximately 75%
of hlh-25 animal; at least one gonad arm contained irregularly shaped oocytes.

After

compartmentalization, the oocytes were more round or tear-drop in shape, and were not tightly
packed (Figure 17).

3.2.5 HLH-25 has a role in Early Embryonic Cell Division
The C. elegans lineage in early embryonic development begins with P0 which divides in
AB and P1. AB further divides into Aba and ABp; P1 further divides into EMS and P2. These
first divisions during embryogenesis require the presence of some of the HLH-25 targets like
ran-1, mex-5, mex-6, and pos-1.

However, hlh-25 is not expressed until ABp and EMS
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granddaughters in response to the Notch signaling [45]. Since C. elegans germline cells have the
ability to silence transgene arrays [96], I wondered if HLH-25 is needed for early cell divisions
even though I did not observe expression at early stages.
To determine whether HLH-25 is required for early cell division, I compared the first five
embryonic cleavages from wild type and hlh-25 animals using α-tubulin::GFP. Images were
taken every three minutes to create a time lapse video. In vivo time-lapse imaging of seven
different embryos reveals that hlh-25 animals have similar first embryonic cleavages to wild
types (Figure 18).

3.3

HLH-25 transcriptional network
I used two different approaches to validate the HLH-25 transcriptional network: reverse

transcriptase quantitative polymerase chain reaction (RT-qPCR) and transcriptional reporters.
RT-qPCR allows quantification of mRNA levels in whole animals. Transcriptional reporters
allow temporal and spatial measurement of the promoter activity in live animals.

3.3.1 Confirmation of HLH-25 target genes by RT-qPCR
Our previous microarray analysis shows that HLH-25 regulates 634 genes of which 510
were up-regulated and 124 were down-regulated. Two of the GO term annotations assigned to
these genes were “embryonic development ending in birth or egg hatching” and “post-embryonic
development”. These results suggest that HLH-25 plays an important role in embryonic and
nematode larval development.
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The microarray analysis was done using young adult worms, which may have contained
developing embryos in their uterus. Since the microarray analysis included genes necessary for
embryonic and larval development, I wondered if HLH-25 regulated genes in both embryos and
in larval/adult animals. To address this, I monitored the change in RNA levels in embryos and
L4 stage larvae. The L4 stage was used to validate the microarray results, while the other stages
were selected to correlate with the hlh-25 gene expression profile. For some genes, I also
measured expression in dauer larvae. I selected 12 genes to validate, and for all 10 of them, in
the L4 stage expression, they were up-regulated or down-regulated to the same extend as
indicated by the microarray analysis (Figure 19, table 2). As described below, the selected genes
are important during embryogenesis and at other stages in the life cycle.
The gene ran-1 encodes the C. elegans Ran GTPase ortholog [97] which, among other
proteins, comprises the Ran GTPase system. The GTPase cycle is known to regulate transport of
proteins across the nuclear envelope [98, 99], chromosome positioning and nuclear envelope
assembly [100]. Previous studies have shown that during embryogenesis ran-1 knock-out causes
improper mitotic spindle formation, irregular chromatin structures, and fission of the pronucleus
during meiosis [97]. This gene was up-regulated in L4-stage animals, but was down-regulated in
embryos.
Genes mex-5, mex-6, and pos-1 encode two CCH-finger proteins that are important for
the establishment of embryonic polarity [101]. These three genes are maternally transcribed.
MEX-5 and MEX-6 establish soma/germline asymmetry in the early embryo. POS-1 is needed
for fate specification of germ cells, pharynx, and intestine during embryogenesis [102]. These
three proteins are needed for the first two cell divisions to occur properly [103]. Mutation to any
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of these genes results in embryonic lethality [77, 103-108]. These three genes were up-regulated
in L4 stage animals and down-regulated during the embryonic stage.
The genes spn-4, cpg-2, emb-9, fat-2, sca-1, lin-37, lin-54 are necessary for
embryogenesis.

Mutations to all of these genes results in embryonic lethality. EMB-9 is

essential for embryonic morphogenesis, gonad elongation, and for larval development; [109].
These genes were up-regulated at the L4 stage. spn-4, cpg-2, emb-9, fat-2, sca-1 were downregulated during the embryo stage.
The genes acs-2, mtl-1, and daf-18 are necessary for homeostasis and stress adaptation
[64, 110, 111]. Mutations to either acs-2 or mtl-1 results in reduced brood size [112, 113]. acs-2
and mtl-1, were down-regulated in the microarray, but up-regulated in my RT-qPCR results at
the L4 stage. daf-18 was up-regulated at all stages tested.

3.3.2 Confirmation of HLH-25 target genes by Transcriptional Reporters
As a second step to validate hlh-25 transcriptional network, I generated transcriptional
reporters for five randomly selected HLH-25 target genes with the goal of establishing their
expression pattern in the presence and absence of hlh-25. I used the green fluorescent protein
gene fused to the promoters of these selected genes to analyze hlh-25 dependent expression in
live animals. The genes chosen were selected because they were strongly up-regulated or downregulated in hlh-25 animals, according to the gene expression microarray, and because they had
potential roles in development. Genes imp-2, ima-1, pqn-95, when mutated, result in embryonic
lethality [106, 107]. In addition to acting within the insulin signaling pathway, the genes akt-2
and daf-18 have antagonistic affects on life span [114-116].
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Although, I successfully cloned the transgenes Pimp-2::GFP, Pdaf-18::GFP, Pima1::GFP, Ppqn-95::GFP, and Pakt-2::GFP, I did not obtain stably transgenic lines. The constructs
were linearized, blunt ended, and injected as a low copy number to prevent transgene silencing
[83]. I learned, practiced and successfully injected the constructs into the animals. As a result, I
obtained F1 progeny that carried the injection marker and displayed the “roller” phenotype;
however the injection marker was never transmitted to F2 progeny. Therefore, I obtained strains
containing akt2::GFP and daf-18::GFP (fsEx84) through other sources. Transgenic lines
carrying akt2::GFP and daf-18::GFP (fsEx84) were kindly provided Dr. Gary Ruvkun from
Harvard Medical School and Dr. Solari Florence from Claude Bernard University Lyon.
To analyze hlh-25 dependent expression of akt-2 and daf-18, I mated hlh-25 males with
hermaphrodites carrying these constructs. Homozygous deletion of hlh-25 was verified by PCR.
I compared the transgene expression in these newly made strains in expression to transgenic
wild-type animals at larval and adult stages.

3.3.2.1 Validation of akt-2 as a target of HLH-25akt-2::GFP
As shown in figure 20, akt-2::GFP is expressed in wild-type animals in head and tail
neurons, the ventral nerve cord, muscles, spermatheca, and in the head posterior bulb. I did not
detect expression in the embryos of adult hermaphrodites. In hlh-25 animals, the spatial akt2::GFP expression was indistinguishable from the pattern in wild-type animals. We were not
able to reliably quantify the GFP levels to determine if there was a detectable difference in the
level of expression.
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3.3.2.2 daf-18 expression increases in the absence of HLH-25
In wild-type animals, daf-18::GFP expression was first detected at the pretzel stage and
continued after hatching, throughout adulthood. The post-embryonic expression was localized
only to the head neurons (Figure 22). In hlh-25 animals, both the spatial distribution and the
level of daf-18::GFP expression increased significantly, and correlated with cells or tissues that
were found to express the Phlh-25: GFP in the head and tail neurons, muscles throughout the
body, pharyngeal muscles, spermatheca and ventral nerve cord (Figure 21) .

3.3.3 Genetic validation that daf-18 is a target of HLH-25
The results presented thus far suggest that HLH-25 transcriptionally represses daf-18.
Based on these data, I hypothesized that hlh-25 animals would have phenotypes that are similar
to animals that overexpress daf-18. Animals with loss of function alleles of daf-18 have shorter
lifespans and are defective in dauer formation [114, 115]. Likewise, animals that overexpress
daf-18 have longer lifespans, are more prone to form dauers, and have difficulty exiting the
dauer stage [65, 117]. Therefore, I tested the lifespan and dauer exit phenotypes of hlh-25
animals.

3.3.4 HLH-25 animals have a longer life span
I measured the mean life span of wild-type and hlh-25 animals at 20 °C. As indicated
in figure 23, hlh-25 animals have a median life span of 19 days, while wild-type animals have a
life span of 16 days (table 3). The extended lifespan of hlh-25 animals is similar to the
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previously reported median lifespan of 17.4 days for daf-18;daf-2 animals expressing an
extrachromosomal copy of daf-18 [117] .

3.3.5 HLH-25 is necessary for proper dauer exit timing
When starvation-induced dauer larvae are placed into favorable growth conditions, they
take approximately 60 minutes to commit to exit the dauer state at 25° C and about ten hours to
molt into the L4 stage [87, 118-120]. Within 60 minutes, the first biological sign of dauer exit is
the increase in fat accumulation or lipophilicity, and pharyngeal pumping starts after
approximately 3 hours [121]. Between nine and twelve hours after the decision to exit dauer,
vulva formation commences and is visible as the vulval crescent. Finally, between 12 and 24
hours, recovering dauers begin to create oocytes and fertilization commences.
In order to determine if dauer recovery depends on HLH-25 regulation of daf-18expression, I compared the dauer recovery phenotypes of wild type animals with: daf-18
mutants, animals over-expressing daf-18 (daf-18GOF) or hlh-25 animals. Because deletion of
hlh-25 increases daf-18 expression, I expected hlh-25 animals and daf-18GOF animals to recover
similarly.
Because the time that it takes for dauer to recover varies and depends on their age and the
environmental factor that caused them to become dauers [87, 118-120], I induced dauer
formation under the same conditions for all strains simultaneously, and used three day old dauers
for the assays.
In my dauer recovery assay, wild-type animals took an average of 12 hours (80%) to
reach L4. As expected, dauer recovery was similar in daf-18 animals but was longer in daf18GOF animals. At 12 hours, 65% of the daf-18 mutants, but only 10% of the daf-18GOF animals,
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had reached L4. Interestingly, the dauer recovery timing of the hlh-25 mutant animals was very
similar to the daf-18GOF. After 12 hours of recovery only 35% of the hlh-25 mutant animals
reached L4. To rescue the wild type phenotype, I reintroduced hlh-25 into hlh-25 animals (hlh25R). Animals carrying hlh-25 as an extrachromosomal array were able to recover similarly to
the wild type animals. They took an average of 12 hours to reach L4 (Figure 24, 26).

3.3.6 DAF-18 does not affect movement
Although a role for daf-18 in locomotion and movement has not been previously
described, I wondered if the locomotion defect of hlh-25 animals is dependent on daf-18.
Therefore, I compared the locomotion and thrashing of daf-18 mutants to wild-type animals as
described above in section 3.2.3. Our results showed that daf-18 animals move at a similar rate
as wild-type animals, and thrash slightly, but not significantly, more than wild-type with an
average of fifteen more lateral movements than wild type per minute (Figure 25).
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Figure 7 Embryonic Expression of Phlh-25::GFP.

The embryo developmental stage is named on the left. The entry zone is marked with
an arrow. The plane of the embryo is marked as A: anterior, P: posterior, D: dorsal, V:
ventral

B
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Figure 8 Embryonic Expression of Phlh-25::GFP.

This figure represents stills from a time lapse video of Phlh-25::GFP
expression during progression from bean to comma stage while still in the
uterus.
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D

Figure 9 Larvae Expression of Phlh-25::GFP..
Expression of Phlh-25::GFP is seen (A)in tail neuron, (B-D) head muscles and (D) body muscles
Larvae stages are specified at the right bottom of each image. Bar marks 20 µm.
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Figure 10 Adult Expression of Phlh-25::GFP.
HLH-25 expression observed in unidentified head neurons and embryos inside the adult
hermaphrodite. Bar marks 25 µm.
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Figure 11 Phlh-25::GFP expression in dauer.
Expression is seen in the VNC and DNC. This image contains two focal plains of GFP
expression in the same animal. (B) and F show the dorsal nerve cord; (C and G) show the
ventral nerve cord. Arrows indicate the synaptic branches between VNC and the dorsal nerve
cord.
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Figure 12 Phlh-25::GFP expression in the dauer head.
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Figure 13 HLH-25 affects embryogenesis.
(A) hlh-25 mutants have a 64% embryonic lethality versus a 14% embryo lethality in wild type
embryos (P-value = 6.32E-14). (B) Deletion of hlh-25 also resulted in a reduced quantity of eggs laid.
hlh-25 animals laid a total average of 208 eggs, while wild-type animals laid an average of 249 (Pvalue = 0.0565). Error bars represent SEM.
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Figure 14 Unfertilized Egg Laying Behavior of hlh-25 compared to wild-type.
Day “1” was assigned for when the egg-laying period started. hlh-25 animals laid an average of 133
unfertilized oocytes while wild-type animals lay laid an average of 27 unfertilized oocytes. Error bars
represent SEM
.
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Figure 17 hlh-25 depletion causes irregular shape of oocytes
HLH-25 affects organization and formation of the germline. hlh-25 animals contained fewere
and irregularly shaped oocytes. The oocyte adjacent to the spermatheca is numbered-1 and
the one farther away are -2, -3. Scale Bar:100µm
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Figure 18 Early Embryonic Cell Division Time-lapse video.
In vivo time-lapse still image of α-tubulin::GFP (which expresses spindle formation) in wildtype and hlh-25 embryos.

43

RT-qPCR
2.5

2

Log2

1.5

1

0.5

0

Figure 19 HLH-25 targets expression during L4 stage.
Graph represents relative gene expression levels. Transcript levels were quantified by RTqPCR. Data are expressed as log2 of fold change.
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Table 2 RTqPCR Log 2 Comparison of hlh-25 with wild-type
Log2
gene

embryo

L4

dauers

mex-5

-0.140859213

0.574520826

-

mex-6

-0.731609333

0.079969371

-

mtl-1

-1.438593174

0.56487424

-

spn-4

-0.755692286

0.947934039

-

lin-54

-

0.425533103

-

lin-37

-

1.48913987

-

ran-1

-0.284879656

0.989225894

-0.558373223

cpg-2

-1.768954799

2.277367657

-1.591294232

pos-1

-0.772183582

1.017858268

0.070098511

emb-9

-0.355788189

0.336756657

0.143902443

fat-2

-0.087547834

1.718457624

-1.883574631

sca-1

-0.244550149

1.270412924

-0.167984707

acs-2

-2.427682984

1.107159331

-1.373822577

daf-18

1.389777859

1.181618478

0.081026597
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Figure 20 akt-2::GFP expression.
akt-2::GFP is expressed in wild-type animals in (A-C) the head and (D-F) the tail
neurons, the (G-I ) the ventral nerve cord, muscles, spermatheca, and in the (A-C)
the head posterior bulb. In hlh-25 animals, the spatial akt-2::GFP expression was
indistinguishable from the pattern in wild-type animals (pictures not shown).
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Figure 21 daf-18 expression changes
In wild-type animals, daf-18::GFP expression was first detected at (A-C) the pretzel
stage, but in a larvae, the expression was only seen in the head (figure 22 a-c). In the
absence of HLH-25, not only the expression in embryos increased significantly (D-F),
but also expression in the the head and tail neuron, muscles throughout the body,
pharyngeal muscles, spermatheca and ventral nerve cord (G-I).
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Figure 22 daf-18 head expression changes
Expression was localized only to the head neurons (A-C), but
in the absence of HLH-25, the expression increased in the
head, (D-F).
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Table 3 Life Span Measurements

Strain
wild-type

hlh-25

Biological
Replicate
1
2
3
all

Total # of Animals
to Die/or
to be Censored
88/13
90/10
86/12
264/35

Median Life Span
of All Animals
(days)
15
17
15
16

1
2
3
all

93/7
93/7
96/4
282/18

20
19
19
19

P-value LogRank
Test compared
to N2 animals

< 0.0001
0.0046
< 0.0001
< 0.0001

Figure 23 Life span curve of wild-type versus hlh-25.
Measurement and comparison of life span between the wild type and hlh-25 on solid NGM
(nematode growth medium) with OP50 E. coli.
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Figure 24 Dauer Recovery.
Visibility of A) pharyngeal pumping and B) crescent formation during
dauer recovery was observed and recorded for twenty-four hours. 0 hrs
marks the time dauers were placed under favorable conditions.

Table 4 Dauer Recovery
wildtype

pumping
crescent

median
p-value
median
p-value

3
12

hlh-25

hlh-25R

daf18-

daf-18GOF

hlh-25 vs
daf-18GOF

12
< 0.0001
24
< 0.0001

3
0.1174
12
0.1745

3
0.3586
12
0.9619

6
< 0.0001
24
< 0.0001

12
0.0004
24
0.0386
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Table 5 Mobility Assay

daf-18- hlh-25R

L4 stage
Locomotion

Strain
Wild-type
hlh-25
daf-18hlh-25R

daf-18- hlh-25R

n
90
90
90
90

mean
70
42
71
44

stdev
8.5
13.8
18.1
24.2

Thrashing
P-value
<.0001
<.0001
<.0001

mean
110
88
125
90

stdev
5.4
11.7
13.8
14

P-value
<.0001
<.0001
<.0001

Figure 25 Locomotion Assay
Error bars represent SEM . (C , D) The band near the middle of the box represents the
median. Outliers are indicated with an asterisk.
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Figure 26 Characteristics of Dauer Recovery
Representative pictures of dauer recovery characteristics on NGM plates. (A) at “0” hour
dauers are long, thin and transparent. The first sign of recovery is (B) fat acuumulation in
the intestines and pharyngeal pumping [1] followed by (C , D) the crescent formation.
Once the dauers reach the adult stage (F) embryos are made and laid.
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4

4.1

DISCUSSION

HLH-25 Functions During Embryogenesis
The experiments in this research lay a foundation for understanding the role of HLH-25 in

C. elegans during embryonic and larval development. The key challenge in this genetic research
was to understand how the HLH-25 transcription factor affects the performances of its target
genes by examining phenotypes caused by hlh-25 mutations. HLH-25 is actively expressed in
embryos, larvae and adults. In the absence of hlh-25, animals show a 54% embryonic lethality, a
reduced brood size, an increased number of unfertilized eggs, a slower movement rate, a longer
life span, and a longer dauer recovery. The results presented offer excellent starting points to
further characterize HLH-25, and raised some questions that can be further examined.
4.1.1 Is hlh-25 a maternal effect gene?
Maternal effects genes play important roles in the early processes of embryonic
development of different organisms, such as sea urchins, nematodes, fruit flies, zebrafish, frogs
and mice. Maternally synthesized proteins or mRNAs are placed in the oocytes and sometime
after fertilization, those mRNAs are expressed in the developing embryo, or zygote. This event
is known as the maternal to zygotic transition (MZT) [122]. During this period, maternal
transcripts are eliminated and the zygotic genome becomes transcriptionally activate [123]. The
timing of MZTs differs from cell to cell, which reflects the development of distinct cell types and
causes the maternal transcripts to overlap with some of the early zygotic transcripts [123].
During Drosophila embryogenesis, maternal mRNAs, such as hunchback, bicoid, and
nanos are required for early patterning of the embryo [9, 124-126]. Firstly, maternal hunchback
is distributed evenly throughout the egg. Maternal nanos mRNAs and bicoid mRNAs are
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localized to the posterior and anterior pole of the mature oocyte, respectively [127]. The nanos
protein inactivates hunchback, preventing its translation in the posterior. Bicoid activates
transcription of the hunchback gene which creates a concentration gradient of the hunchback
expression along the embryo. Hunchback activates or represses several genes depending on its
concentration. For instance, hunchback activates and represses kruppel [127, 128] . Kruppel is
necessary for differentiation, growth, and development of the embryo. At high concentrations,
hunchback represses kruppel, and at lower concentrations hunchback activates kruppel [128].
The maternal effect hunchback, along with other maternal effect genes, initiates the
embryo pattern. Zygotic hunchback transcription creates a gradient of the hunchback protein
which regulates genes necessary for embryo development [122]. Hunchback is necessary for
proper morphology [122, 129-132]. Drosophila with hunchback mutations lack mouthparts and
thorax structures [122, 129-132].
Different methods have been utilized to identify maternal genes in Drosophila, one of
which is to isolate pole cells, progenitors of the germ-line stem cells, from blastodermal embryos
by fluorescence-activated cell sorting (FACS) and then use these isolated cells in a microarray
analysis [133, 134]. Another method is to use flow cytometry to sort GFP-labeled pole cells then
use multidimensional protein identification technology (MuDPIT) [134-137] to identify proteins
in both the GFP-positive and GFP-negative cells. Moreover, another method is to observe
mRNA molecule localization by using fluorescent labeled probes [138].
In C. elegans, oocytes are loaded with a number of maternally synthesized proteins and
mRNAs that are necessary for directing the first mitotic divisions. These include mex-5, mex-6,
and pos-1 mRNA, all of which are required to establish the overall polarity of the embryo, and
ran-1 mRNA, which is necessary for the first embryonic division. Mutation of ran-1 disrupts

54

formation of the mitotic spindle and causes aberrant chromatin localization [97]. This raises the
question about whether hlh-25 is also a maternal effect gene.
Three observations from our experiments lead us to suggest that HLH-25 is not a
maternal effect gene. First, movies show that the early embryonic divisions of hlh-25 animals
appear normal. Second, hlh-25 is expressed in early embryos in response to Notch signaling in
the Abp granddaughters (beginning after the eight-cell stage) and in four of the EMS
granddaughters (MSaa, MSap, MSpa,Mspp). The maternal-to-zygotic transition (MZT) begins
after the second cleavage (4 Cells) [123, 139], so HLH-25 is likely just becoming active after the
Notch-dependent induction of transcription. Third, hlh-25 expression has not been detected in
the somatic gonad, the intestine, or the germline of adult animals, though it is possible that our
transgene does not reflect the full expression pattern of the gene. In future studies to test more
directly whether hlh-25 is or not a maternal effect gene, methods described above should be
used.

4.2

Why is the morphology of oocytes irregular in hlh-25 animals? Why do hlh-25 animals
have a high embryonic lethality, increased quantity of unfertilized eggs and reduced
brood size?
We have established that different HLH-25 target genes play different roles during

embryogenesis. Some of these genes, such as cpg-2 and H02I12.5, are necessary during oocyte
formation [139], while others are necessary after fertilization, such as ran-1. When these
important genes are mutated or down-regulated (as they are in hlh-25 animals), embryos
encounter different problems such as irregular oocyte formation and/or embryonic lethality. This
may explain why hlh-25 animals have irregular shaped oocytes, high embryonic lethality, an
increased in unfertilized oocytes and reduced brood size.
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hlh-25 embryos that die do so prior to the tadpole stage; however, it is unknown exactly
at what cell stage embryos stop dividing and die. Using Hoechst dye blue fluorescent stain
(DAPI) to stain DNA in the nucleus of the embryos could be a method for future studies to
confirm at which cell stage embryos arrest. Also, since overexpression of PTEN/daf-18 causes
apoptosis of cells [140], future studies should use the TUNEL (Terminal deoxynucleotidyl
transferase dUTP nick end labeling) assay to detect DNA fragmentation from apoptotic cells in
hlh-25 unhatched embryos. Furthermore, strains co-expressing fluorescent markers that target the
plasma membrane (GFP fusion that binds PI4, 5P2) and the chromosomes (mCherry-histone
H2B) to observe plasma membrane and chromosome, respectively, should be used as a method to
further study the gonad architecture in hlh-25 animals.

4.3

HLH-25 Function in Movement

4.3.1 Are hlh-25 animals UNC variants?
C. elegans move in a wave-like motion that is described as sinusoidal movement [141].
This movement pattern is determined by antagonist movement of the ventral and dorsal body
muscles, and it is controlled by distinct classes of motorneurons [142]. Some of these neurons
form neuromuscular junctions with the ventral and dorsal body muscles, one of which is the
ventral nerve cord (VNC) [142]. The expression of hlh-25 in the ventral nerve cord led us to
examine hlh-25 animals for locomotion defects.
Even though hlh-25 animals appear to have a sinusoidal movement, they move at a
slower rate than wild-types. However, this phenotype could not be rescued. The failure to rescue
the phenotype by re-introducing the transgene suggests that HLH-25 does not function in
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locomotion. There are two other alternative possibilities. First, the hlh-25 deletion was created
using EMS (Ethyl methanesulfonate), which produces random mutations in the genetic material.
Although, hlh-25 animals were extensively outcrossed in order to reduce genetic abnormalities,
there could be a mutation in a gene located close to hlh-25 and on the same chromosome that is
necessary for movement. Second, it is possible that the transgene is not expressed at high
enough levels in the cells to rescue movement. Future studies can address these possibilities, by
testing additional transgenic lines, which may express hlh-25 in different cells, for the ability to
rescue the movement phenotype.

4.4

Stage Dependent Regulation by HLH-25

4.4.1 Does HLH-25 act as both, a transcriptional activator and a transcriptional repressor?
Generally, transcription factors are characterized by their mechanism of transcriptional
regulation. Transcription factors typically act to either repress or activate transcription: many
may activate one group of genes while and to repress a different group of genes [143, 144] .
Importantly, only a few transcription factors are known to act both as an activator and as a
repressor of the same gene. For instance, Mcml, a yeast transcription factor, affects both
activation and repression of α-specific genes [145] in yeast mating-type switching. In
Arabidopsis, the homeodomain-leucine zipper ATHB2 and the basic helix–loop–helix (bHLH)
PIL1 transcription factor, activate genes implicated in the elongation response provoked by
neighbor shade, and repress the same genes when neighbor shade is no longer detected [146,
147].
Our results show that in C. elegans a number of the genes that are activated by HLH-25
during embryogenesis are repressed by HLH-25 in during L4 stage. In order to attempt to
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explain why hlh-25 activates and represses some of its target genes but only represses daf-18, I
looked for the hlh-25 binding sites within 2000 base pairs upstream of the ATG start codon of
the target genes previously validated by RTqPCR. As explained in section 1.3, HLH-25
recognizes five different consensus sequences. Genes cpg-2 and ima-1, have three of the five
HLH-25 consensus sequence binding site [55]. Genes ran-1, pos-1, imp-2, pqn-95, acs-2 and
daf-18 only have one of the five HLH-25 consensus sequence binding sites (Table 5) [55]. Even
though HLH-25 both activates and represses acs-2 and only represses daf-18, these genes share
the same HLH-25 consensus sequence binding site, “CACACG”. This result raises the question
of whether HLH-25 regulates gene expression in a stage-dependent manner. To examine this,
future studies should prepare microarrays comparing wild-types with hlh-25 mutants at all
stages.
Table 5 Location of the HLH-25 binding sites

Gene

cpg-2

ima-1
pos-1
ran-1
sca-1
emb-9

Consensus
Sequence
CATACG
CACACG
CATGCG
CACGCG
CATGCG
CATACG
CACGCT
CACGCT
none
none

Location
Upstream of the
ATG
-129
-608
-1614
-264
-311
-991
-636
-1948
-

Gene
daf-18
lin-34
mtl-1
pqn-95
imp-2
mex-5
mex-6
spn-4
acs-2

Consensus
Sequence
CACACG
CATGCG
CACGCT
CACACG
CATGCG
CATACG
none
none
CACGCT
CACACG

Location
Upstream of the
ATG
-468
-1694
-1533
-398
-537
-1512
-415
-281
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4.5

HLH-25 links Notch signaling to the PTEN pathway.

DAF-18, in C. elegans, is the ortholog of the human tumor suppressor PTEN (phosphatase
and tensin homolog), and HLH-25 is an ortholog of Hairy/Enhancer of Split (HES). Both of
them are important for development. PTEN, helps regulate the cell cycle and cell division
through the PI3-kinase pathway [26, 148, 149] by dephosphorylating PIP3
(phosphatidylinositol-3,4,5-trisphosphate) [150]. Either PTEN gain of function or loss of
function causes irregularities in development. For instance, mutations to PTEN have been
associated with the autosomal-dominant disorder Cowdens-Disease and with different types of
cancer such as prostate cancer and malignant glioma. Overexpression of PTEN induces
apoptosis and cell cycle arrest. For instance, overexpression of PTEN in MCF-7 breast cancer
cells, causes G1 cell arrest and cell death [140]. Furthermore, HES proteins are important
regulators of a variety of genes that influence cell proliferation and differentiation in embryo
development [38]. HES mutations have been associated with lung and breast cancer in mammals
[43, 44] and with oocyte death [29].
HES and HLH-25 are direct targets of Notch signaling [34-36, 45]. Our findings show that
daf-18 expression is regulated by HLH-25, providing a link between Notch signaling and PTEN
mediated control of cell proliferation. Future studies in the lab can further exploit the
relationship between HLH-25 and daf-18 by analyzing the expression of daf-18::GFP in animals
lacking the Notch signaling, LIN-12/Notch.
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Figure 27 Role comparisons between humans and C. elegans.
This diagram is based on previous experiments and the one presented here. In humans, HES
is activated by Notch signaling. HES represses PTEN. PTEN prevents AKT complex
phosphorylation allowing mTOR to enter the nucleus to control cell cycle. Similarly, in C.
elegans, HLH-25 is activated by Notch signaling. HLH-25 represses daf-18/PTEN. daf18/PTEN prevents AKT complex phosphorylation allowing DAF-16 to enter the nucleus.
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Table 6 Primers
The Thermo Fisher Scientific guidelines were followed to design primers that. The Oligo Analyzer byIntegrated DNA
Technologies was used to analyze the primers and make sure they met the requirements. The National Center for Biotechnology
Information (NCBI) nucleotide database and Wormbase was used to find the base upstream sequences of each of the selected
genes.
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Table 7 RTqPCR Probes
Gene
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Gene
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Gene
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